 |
| Precision Medicine Market |
Precision
medicine is an emerging field, which tailors the
treatment according to the individual’s genetic makeup, lifestyle,
and environment. The precision medicine have gained popularity due to
the positive result obtained by precision medicine in treatment of
cancer. It allows the doctors and researchers to predict more
accurate treatment and preventive strategies for any particular
disease. Precision medicine has also challenged the approach of one
drug fits all, as every person has unique genetic structure, which
makes it impossible for one drug to work on whole population.
Precision medicine is also known personalized medicine or
individualized medicine, which target the mutations of normal body
cells into cancerous cells. The use of precision medicine in targeted
treatment specifically with cancer cells tends to experience less
side effects with quick recovery as compared to conventional drugs.
Download
PDF Brochure of Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/145
Market
Dynamics:
The
two recent FDA drug approvals, Kalydeco (ivacaftor) and Keytruda
(pembrolizumab), pertaining to 33 cystic fibrosis mutations and
cancer treatment based on a genetic feature respectively, point to an
encouraging future for precision medicine. National Cancer Institute
(NCI) conducts NCI-COG Pediatric MATCH trial that enrolls children
and adolescents by advanced cancer therapy based on their genetic
abnormality, where NCI also plans to support new immunotherapy
clinical trials, antibody, testing of new combinations of the cell,
small molecule, and radiation therapy studies, which include
sequencing of tumor specimens. In July 2017, NCI has also launched
various precision medicine trials, which include Adjuvant Lung Cancer
Enrichment Marker Identification and Sequencing Trials (ALCHEMIST),
Lung Cancer Master Protocol (Lung-MAP), Molecular Analysis for
Therapy Choice (NCI-MATCH), and Molecular Profiling-Based Assignment
of Cancer Therapy (NCI-MPACT).
Regional
Analysis:
North
America accounts for the largest share in the global precision
medicine market, followed by Europe. This is mainly attributed to
awareness and initiative related to precision medicine in the North
America. In 2015 President Obama announced the launch of Precision
Medicine Initiative, that aimed to revolutionize the way of treatment
to improve the health, as precision medicine provide an innovative
approach that studies the unique gene sequences of individual and
offer the tailored treatment. Precision Medicine Initiative have led
to powerful novel discoveries and several advanced treatments, which
are tailored for specific characteristic such as, genetic makeup or
genetic profile of an individual tumor that helps to transform the
way of treatment and favors the growth of precision medicine market
in near future. The precision medicine initiative invested US$215
million in the National Institutes of Health in fiscal 2016 budget,
which is expected to accelerate biomedical research by providing
advanced tools and innovative therapies to the physicians, which are
tailored according to individual need, in turn fueling the growth of
precision medicine market in near future.
Competitive
Landscape:
Some
major players operating in the precision medicine market includes;
•
Intomics
•
ferrer incode
•
Nanostring Technologies, Inc.
•
Tepnel Pharma Services
•
Pfizer, Inc.
•
Novartis AG
•
Teva Pharmaceuticals
•
Merck & Co., Inc.
•
Qiagen N.V.
•
Quest Diagnostics
Market
Taxonomy:
This
report segments the global precision medicine market on the basis of
technology and application. On the basis of technology, the global
precision medicine market is segmented into bioinformatics, gene
sequencing, drug discovery, precision molecular diagnostics, and big
data analytics. Applications of precision medicine include oncology,
CNS, hematology, respiratory, and immunology, among others.
Detailed
Segmentation:
Global
Precision Medicine Market, By Technology:
•
Bioinformatics
•
Gene Sequencing
•
Drug Discovery
•
Precision Molecular Diagnostics
•
Big Data Analytics
Global
Precision Medicine Market, By Application:
•
Oncology
•
Breast cancers
•
Lung Cancer
•
Others
•
CNS
•
Hematology
•
Respiratory
•
Immunology
•
Others
Global
Precision Medicine Market, By Geography:
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East
•
Africa
If
You Have Specific Requirement? Ask Our Experts @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/145
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
0 comments:
Post a Comment